Machine Learning‐Based Signature for Predicting Prognosis and Drug Sensitivity in Ovarian Cancer With Macrophage M2‐Related Genes

Xianxi Liu; Xinhua Huang; Lifei Wang; Ruiqian Liu; Yang Liu; Xianxi Liu; Xinhua Huang; Lifei Wang; Ruiqian Liu; Yang Liu

doi:10.1155/ecc/6308930

2025 Volume 2025

Article Contents

Next Previous

RESEARCH ARTICLE Open Access

Machine Learning‐Based Signature for Predicting Prognosis and Drug Sensitivity in Ovarian Cancer With Macrophage M2‐Related Genes

More Information

Published online: 23 June 2025
European Journal of Cancer Care 2025, Article number: 10.1155/ecc/6308930 (2025) | Cite this article

Rights and permissions
Copyright: © 2025 by the author(s). Exclusive Licensee Maximum Academic Press, Fayetteville, GA. This article is an open access article distributed under Creative Commons Attribution License (CC BY 4.0), visit https://creativecommons.org/licenses/by/4.0/.

About this article

Cite this article

Xianxi Liu, Xinhua Huang, Lifei Wang, Ruiqian Liu, Yang Liu. 2025. Machine Learning‐Based Signature for Predicting Prognosis and Drug Sensitivity in Ovarian Cancer With Macrophage M2‐Related Genes. European Journal of Cancer Care. 2025: doi: 10.1155/ecc/6308930

Xianxi Liu, Xinhua Huang, Lifei Wang, Ruiqian Liu, Yang Liu. 2025. Machine Learning‐Based Signature for Predicting Prognosis and Drug Sensitivity in Ovarian Cancer With Macrophage M2‐Related Genes. European Journal of Cancer Care. 2025: doi: 10.1155/ecc/6308930

Download PDF

Article Metrics

Article views(15) PDF downloads(12)